KALA BIO, INC. Business Combination, Contingent Consideration, Liability, Noncurrent
KALA BIO, INC. (KALA) had Business Combination, Contingent Consideration, Liability, Noncurrent of $3.23 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent · last filed 2026-04-15
- 2025-06-30: Business Combination, Contingent Consideration, Liability, Noncurrent $3.23M.
- 2025-03-31: Business Combination, Contingent Consideration, Liability, Noncurrent $3.12M.
- 2024-12-31: Business Combination, Contingent Consideration, Liability, Noncurrent $4.66M.
- 2024-09-30: Business Combination, Contingent Consideration, Liability, Noncurrent $4.66M.
| Period end | Business Combination, Contingent Consideration, Liability, Noncurrent |
|---|---|
| 2025-06-30 | $3.23M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $3.12M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $4.66M 10-K · filed 2026-04-15 |
| 2024-09-30 | $4.66M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $4.24M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $4.27M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $4.11M 10-K · filed 2025-03-31 |
| 2023-09-30 | $3.84M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $5.59M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $5.23M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $4.22M 10-K · filed 2024-03-29 |
| 2022-09-30 | $3.78M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $3.84M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $4.00M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $4.84M 10-K · filed 2023-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |